Log In
Print
BCIQ
Print
Print this Print this
 

ALKS 5461

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionCombination of ALKS 33, an opioid receptor modulator, and buprenorphine
Molecular Target Mu opioid receptor (OPRM1) (MOR) ; Kappa opioid receptor (OPRK1) (KOR)
Mechanism of ActionMu opioid receptor agonist; Kappa opioid receptor antagonist
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today